We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Targeting Diseased Areas using Enzyme-Sensitive Contrast Agents for MRI

By MedImaging staff writers
Posted on 16 Jun 2008
Magnetic resonance imaging (MRI) has become a standard modality in clinical diagnosis due to the use of contrast agents, which enable the contrast between healthy tissue and diseased tissue to be increased. More...
However, the agents currently used clinically do not allow the identification of particular pathologies or of the affected area of the body. The recent work of two French teams has brought hope in this area.

The recent research of two CNRS (Centre National de la Recherche Scientifique; Vandoeuvre-lès-Nancy [near Nancy], France) teams from Orleans and Gif-sur-Yvette (Orleans' Centre de Biophysique Moléculaire and the Institut de Chimie des Substances Naturelles in Gif-sur-Yvette [near Paris]) have demonstrated that by using a new class of contrast agents sensitive to enzymes, it is possible to locate the affected part of the body. The molecules act as switches--when they encounter a specific enzyme, this initiates a cascade reaction, leading to the activation of the contrast agent, which then becomes detectable in an MRI image. The systems have two positions--they are "off” in the absence of the enzyme, and "on” if present. Therefore, an image is only received when the contrast agents are activated.

The reactions caused by certain enzymes may be an indication of the state of the cells, and be interpreted as the signature of a given disease process. In the future, detection of enzymes due to these contrast agents should enable clinicians to diagnose a disease with a simple MRI examination. Moreover, the system can be modulated and is potentially applicable to a large variety of enzymes, and, therefore, pathologies.

Understanding the mechanism of these new molecules for medical imaging constitutes a major advance in visualizing molecular processes in vivo, as well as in detecting pathologies.

Founded in 1939 by French governmental decree, CNRS' goals include: to evaluate and carry out all research capable of advancing knowledge and bringing social, cultural, and economic benefits for society; contribute to the application and promotion of research results; develop scientific information and support research training; and participate in the analysis of the national and international scientific climate and its potential for evolution to develop a national policy.


Related Links:
CNRS

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Morcellator
TCM 3000 BL
Isolation Stretcher
IS 736
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.